CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
14.05
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.90
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.021947 %
Charges from full value of position ($-4.17)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.021947%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000275 %
Charges from full value of position ($-0.05)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000275%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency SEK
Margin 5%
Stock exchange Sweden
Commission on trade 0%

*Information provided by Capital.com

Orexo AB ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 8.44-20.50
Average Volume (10 days) 24.10K
Average Volume (3 months) 629.64K
Market Cap 494.28M
P/E Ratio -100.00K
Shares Outstanding 35.15M
Revenue 628.60M
EPS -5.86
Dividend (Yield %) N/A
Beta 0.69
Next Earnings Date Jan 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2024 14.05 0.00 0.00% 14.05 14.05 14.05
Feb 12, 2024 14.05 0.05 0.36% 14.00 14.05 13.95
Jan 30, 2024 14.75 -0.05 -0.34% 14.80 14.80 14.75
Jan 29, 2024 13.85 0.05 0.36% 13.80 13.85 13.75
Jan 26, 2024 13.90 0.00 0.00% 13.90 13.90 13.90
Jan 25, 2024 14.00 0.25 1.82% 13.75 14.00 13.75
Jan 19, 2024 13.80 0.00 0.00% 13.80 13.80 13.75
Jan 18, 2024 13.75 0.00 0.00% 13.75 13.85 13.75
Jan 16, 2024 13.95 0.00 0.00% 13.95 13.95 13.70
Jan 15, 2024 14.20 -0.05 -0.35% 14.25 14.25 14.20
Jan 12, 2024 14.20 -0.30 -2.07% 14.50 14.60 14.20
Jan 11, 2024 14.85 -0.20 -1.33% 15.05 15.05 14.80
Jan 8, 2024 14.75 0.05 0.34% 14.70 14.95 14.65
Jan 5, 2024 14.85 0.05 0.34% 14.80 14.85 14.80
Jan 4, 2024 14.90 0.00 0.00% 14.90 15.00 14.90
Jan 3, 2024 15.20 0.00 0.00% 15.20 15.20 15.20
Dec 29, 2023 15.15 0.00 0.00% 15.15 15.20 15.15
Dec 28, 2023 15.50 -0.15 -0.96% 15.65 15.70 15.50
Dec 22, 2023 15.70 -0.05 -0.32% 15.75 15.75 15.55
Dec 21, 2023 15.85 0.00 0.00% 15.85 16.00 15.85

Orexo Events

Time (UTC) Country Event
Thursday, April 25, 2024

Time (UTC)

06:00

Country

SE

Event

Q1 2024 Orexo AB Earnings Release
Q1 2024 Orexo AB Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 624.3 565 663.6 844.8 783.1
Revenue 624.3 565 663.6 844.8 783.1
Cost of Revenue, Total 102.6 78.9 65.6 105.6 171.8
Gross Profit 521.7 486.1 598 739.2 611.3
Total Operating Expense 808.2 779.1 683.5 613.6 687.3
Selling/General/Admin. Expenses, Total 390.8 427.8 382.1 329.4 355.9
Research & Development 259.7 223.1 193.3 163.4 148.2
Depreciation / Amortization 68.8 53.3 38.9 20 20.8
Other Operating Expenses, Total -6.7 -0.1 1.2 -2.6 -9.4
Operating Income -183.9 -214.1 -19.9 231.2 95.8
Interest Income (Expense), Net Non-Operating 18.2 1.8 -14 1.9 -1.9
Other, Net -4.7 -10.2 -4.4 -5.2 -1.7
Net Income Before Taxes -170.4 -222.5 -38.3 227.9 92.2
Net Income After Taxes -177.6 -223.5 -84.4 219.1 137.9
Minority Interest 0
Net Income Before Extra. Items -177.6 -223.5 -84.4 219.1 137.9
Net Income -177.6 -223.5 -84.4 219.1 137.9
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items -177.6 -223.5 -84.4 219.1 137.9
Income Available to Common Incl. Extra. Items -177.6 -223.5 -84.4 219.1 137.9
Diluted Net Income -177.6 -223.5 -84.4 219.1 137.9
Diluted Weighted Average Shares 34.3517 34.3196 34.3988 35.3485 35.096
Diluted EPS Excluding Extraordinary Items -5.17004 -6.5123 -2.45357 6.19829 3.92922
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Diluted Normalized EPS -1.90034 -0.65429 0.86079 6.19829 3.92922
Interest Expense (Income) - Net Operating -6.8 -3.9 2.4 -2.2
Unusual Expense (Income) -0.2
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 157.7 158.8 156 161 147.8
Revenue 157.7 158.8 156 161 147.8
Cost of Revenue, Total 17.2 28.7 25.9 28 21.2
Gross Profit 140.5 130.1 130.1 133 126.6
Total Operating Expense 170.6 218.1 227.1 210.8 197.5
Selling/General/Admin. Expenses, Total 86.5 112 116 108.9 101.7
Research & Development 75.6 78.5 88.2 76.5 81.3
Other Operating Expenses, Total -8.7 -1.1 -3 -2.6 -6.7
Operating Income -12.9 -59.3 -71.1 -49.8 -49.7
Interest Income (Expense), Net Non-Operating -2.9 -9.1 -24.4 27.4 12.3
Net Income Before Taxes -15.8 -68.5 -95.5 -22.4 -37.4
Net Income After Taxes -12.6 -63.9 -91.8 -26.5 -35.7
Net Income Before Extra. Items -12.6 -63.9 -91.8 -26.5 -35.7
Net Income -12.6 -63.9 -91.8 -26.5 -35.7
Income Available to Common Excl. Extra. Items -12.6 -63.9 -91.8 -26.5 -35.8
Income Available to Common Incl. Extra. Items -12.6 -63.9 -91.8 -26.5 -35.8
Diluted Net Income -12.6 -63.9 -91.8 -26.5 -35.8
Diluted Weighted Average Shares 34.4158 34.3676 34.3636 34.3676 34.3676
Diluted EPS Excluding Extraordinary Items -0.36611 -1.85931 -2.67143 -0.77107 -1.04168
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Diluted Normalized EPS 0.10039 -0.68669 -1.66892 0.11217 -0.02415
Total Adjustments to Net Income -0.1
Other, Net -0.1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 735.5 865.5 831.6 1221.2 1059.5
Cash and Short Term Investments 351.8 504.1 505.3 816.8 589.8
Cash 132.2 504.1 505.3 816.8 589.8
Total Receivables, Net 293.6 256.7 207.5 261.1 291.9
Accounts Receivable - Trade, Net 246.5 214 165.2 233.8 264.5
Total Inventory 74.6 92.3 108.4 131.8 173.6
Prepaid Expenses 15.4 12.5 10.3 11.4 4.2
Total Assets 1109 1273.7 1232.9 1501.1 1286.7
Property/Plant/Equipment, Total - Net 122.1 125.1 115.1 79 20
Property/Plant/Equipment, Total - Gross 190.9 191.7 175.5 135.3 77.5
Accumulated Depreciation, Total -68.8 -66.5 -60.4 -56.3 -57.3
Intangibles, Net 217.4 248.9 252.8 113.9 103.9
Long Term Investments 0.9 0.8 0.7 1.4 10.4
Other Long Term Assets, Total 33.1 33.4 32.7 85.6 92.9
Total Current Liabilities 385.9 380.2 601.3 461 483.4
Accounts Payable 86.6 49.2 47 49.4 47.7
Accrued Expenses 135.6 133.7 107.2 116.2 165
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 143.1 177.1 203.5 274 270.7
Total Liabilities 915.1 924.1 674.4 794.7 810.6
Total Long Term Debt 519 530.3 47.4 322.9 320.6
Long Term Debt 494.8 492.3 0 289.6 320.6
Other Liabilities, Total 10.2 13.6 25.7 10.8 6.6
Total Equity 193.9 349.6 558.5 706.4 476.1
Common Stock 14.2 14.2 14.2 14.2 14.2
Additional Paid-In Capital 1815.9 1816 1814.4 1861.4 1853.6
Retained Earnings (Accumulated Deficit) -1657.9 -1480.2 -1256.7 -1172.3 -1391.4
Other Equity, Total 21.7 -0.4 -13.4 3.1 -0.3
Total Liabilities & Shareholders’ Equity 1109 1273.7 1232.9 1501.1 1286.7
Total Common Shares Outstanding 34.3676 34.3279 34.7106 35.4906 35.1255
Other Current Assets, Total 0.1 -0.1 0.1 0.1
Current Port. of LT Debt/Capital Leases 20.6 20.2 243.6 21.4
Capital Lease Obligations 24.2 38 47.4 33.3
Short Term Investments 219.6
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 518.1 568.7 589.3 735.5 827.7
Cash and Short Term Investments 184.2 251.1 278.9 351.8 443.9
Cash 184.2 251.1 142.4 132.2 122.4
Total Receivables, Net 269.3 250.5 245.7 272.4 295.1
Accounts Receivable - Trade, Net 269.3 250.5 245.7 246.5 295.1
Total Inventory 64.6 67.1 64.7 74.6 88.7
Total Assets 869 926.9 949.3 1109 1203.5
Property/Plant/Equipment, Total - Net 114.5 115.4 112.2 122.1 116.9
Intangibles, Net 186.4 197.8 207.2 217.4 229.6
Long Term Investments 0.8 0.3 0.9 0.9 1
Other Long Term Assets, Total 49.2 44.7 39.7 33.1 28.3
Total Current Liabilities 309.7 304 305.7 385.9 375.3
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 21.3 21.8 178.4 20.6 21.2
Other Current Liabilities, Total 288.4 282.2 127.3 143.1 354.1
Total Liabilities 777 803.1 820.2 915.1 905.1
Total Long Term Debt 457.4 495.3 508.2 519 520.8
Long Term Debt 447.8 481 489.1 494.8 494.2
Capital Lease Obligations 9.6 14.3 19.1 24.2 26.6
Other Liabilities, Total 9.9 3.8 6.3 10.2 9
Total Equity 92 123.8 129.1 193.9 298.4
Other Equity, Total 92 123.8 129.1 193.9 298.4
Total Liabilities & Shareholders’ Equity 869 926.9 949.3 1109 1203.5
Total Common Shares Outstanding 34.3676 34.3676 34.3676 34.3676 34.3279
Other Current Assets, Total 0.1
Prepaid Expenses 36.6
Accounts Payable 86.6
Accrued Expenses 135.6
Short Term Investments 0 0 136.5 219.6 321.5
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -183.9 -214.1 -19.9 231.2 95.8
Cash From Operating Activities -156.6 -228.9 16.7 287 242
Cash From Operating Activities 68.7 53 38.9 41 20.8
Non-Cash Items -72.2 -69.8 -46 0.3 41.1
Changes in Working Capital 30.8 2 43.7 14.5 84.3
Cash From Investing Activities -234.7 -52.9 -189.1 -22.4 -6.2
Capital Expenditures -23.9 -52.8 -189.7 -32 -6.1
Other Investing Cash Flow Items, Total -210.8 -0.1 0.6 9.6 -0.1
Cash From Financing Activities -21.4 250.6 -111.3 -53.7 0
Issuance (Retirement) of Stock, Net 0 -27.3 2 0
Issuance (Retirement) of Debt, Net -21.4 250.6 -84 -55.8 0
Foreign Exchange Effects 40.9 30 -27.8 16.1 26.1
Net Change in Cash -371.8 -1.2 -311.5 227 261.9
Cash Taxes Paid -1.5 -8.2 -0.6 12.2 18.1
Cash Interest Paid 22.4 22.9 11.8 17.7 14.8
Financing Cash Flow Items 0.1
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -59.3 -183.9 -112.8 -62.9 -13.2
Cash From Operating Activities -61.5 -156.6 -107.8 -47.1 -61.7
Cash From Operating Activities 18.2 68.7 50.7 33.2 16
Non-Cash Items 1.4 -72.2 -49.8 -33.2 -22.8
Cash Taxes Paid 1.1 -1.5 2.1 0.7 -1.9
Cash Interest Paid 7.7 22.4 15.6 9.7 4.7
Changes in Working Capital -21.8 30.8 4.1 15.8 -41.7
Cash From Investing Activities 83.1 -234.7 -300.9 -231.9 -5.6
Capital Expenditures -0.8 -23.9 -11.6 -10.1 -5.6
Other Investing Cash Flow Items, Total 83.9 -210.8 -289.3 -221.8
Cash From Financing Activities -7.8 -21.4 -15.6 -10.6 -5.3
Issuance (Retirement) of Stock, Net 0
Issuance (Retirement) of Debt, Net -7.8 -21.4 -15.6 -10.6 -5.3
Foreign Exchange Effects -3.6 40.9 42.6 29.7 6.3
Net Change in Cash 10.2 -371.8 -381.7 -259.9 -66.3
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Novo Holdings A/S Venture Capital 27.7816 9643184 0 2023-09-30 LOW
Avanza Bank Holding AB Holding Company 7.61 2641475 -54642 2023-09-30 LOW
ATP Pension Fund 5.1299 1780633 0 2023-09-30 LOW
Walldov (Anders) Individual Investor 4.6095 1600000 0 2023-09-30 LOW
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 2.786 967053 1000 2023-09-30 LOW
Nordnet Pensionsforsakring AB Corporation 1.5651 543269 44285 2023-09-30 LOW
Hansson (Stefan) Individual Investor 1.1998 416457 19896 2023-09-30 LOW
Nyström (Christer) Individual Investor 0.9635 334452 51696 2023-09-30 LOW
Sjätte AP-Fonden Pension Fund 0.8057 279663 -111268 2023-06-30 LOW
Eccenovo AB Corporation 0.735 255132 0 2023-09-30 LOW
Lejonkula (Hakan) Individual Investor 0.6252 217000 -3000 2023-09-30 LOW
Lundqvist (Thomas) Individual Investor 0.5893 204567 0 2023-09-30 LOW
Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 0.566 196459 9448 2023-09-30 LOW
Rantanen (Jonas) Individual Investor 0.5114 177500 177500 2023-09-30
Consultinvest Asset Management SGR S.p.A. Investment Advisor 0.5083 176445 0 2023-09-30 LOW
SEB Investment Management AB Investment Advisor 0.4774 165693 -81 2023-09-30 LOW
Sorensen (Nikolaj Arrild) Individual Investor 0.3503 121605 32740 2022-12-31 LOW
Skandia Fonder AB Investment Advisor 0.2779 96478 0 2023-09-30 LOW
Pekao Towarzystwo Funduszy Inwestycyjnych SA Investment Advisor 0.1348 46785 46785 2022-06-30 LOW
Skandia Investment Management AB Investment Advisor 0.0931 32328 0 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

ORX Company profile

Orexo is a Sweden-based healthcare company, specialising in improved pharmaceuticals. The company develops patented drugs by bringing new technologies into documented substances. Orexo primarily addresses opioid dependence, pain, and some therapeutic areas. The company’s key market is the US, where opioid dependence is at its highest. Orexo’s landmark products include Abstral for alleviating cancer pain, the sleeping pill Edluar, and two products for the Helicobacter pylori diagnosis. The Orexo subsidiary portfolio features such companies as Orexo UK, Pharmacall, Noster System, and Pharmakodex, among others. Orexo trades on the NASDAQ Stockholm under the ORX ticker. Explore the ORX stock investment opportunities at Capital.com.
Industry: Proprietary & Advanced Pharmaceuticals

Rapsgatan 7E
UPPSALA
UPPSALA 751 05
SE

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

US100

17,866.80 Price
-0.500% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.57 Price
-3.160% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

2,034.09 Price
+0.150% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 22:00 (UTC)
Spread 0.30

Oil - Crude

78.49 Price
+0.150% 1D Chg, %
Long position overnight fee 0.0219%
Short position overnight fee -0.0438%
Overnight fee time 22:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading